Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation
 
 

Browse Conferences
 
 
 
25 Results Found, Showing 1 - 25
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
Keywords:
Click here to clear this filter
 
 
Go
Show only the content that I own
 
 
October 17, 2009 - Saturday
 
SA03 - Molecular Testing in Breast Cancer 
Relevancy:
64.15% 
 
Date/Time:
October 17, 2009   9:20am - 9:55am
 
Length:
32m 29s - 67 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Ronald H. Blum, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA03 - Molecular Testing in Breast Cancer 
Relevancy:
64.15% 
 
Date/Time:
October 17, 2009   9:20am - 9:55am
 
Length:
32m 29s - 67 Slides  
 
Speaker:
Ronald H. Blum, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Relevancy:
50.36% 
 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Relevancy:
50.36% 
 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
62.69% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
62.69% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 24, 2009 - Thursday
 
rating
U101 - Prostate Cancer Screening: Where Do We Stand? 
Relevancy:
67.45% 
 
Date/Time:
September 24, 2009   1:00pm - 1:30pm
 
Length:
36m 34s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Peter R. Carroll, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
U102 - The Risks and Benefits of Chemoprevention in Prostate Cancer 
Relevancy:
61.41% 
 
Date/Time:
September 24, 2009   1:35pm - 2:05pm
 
Length:
30m 16s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew J. Stephenson, MD, FRCSC (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON104 - EBP Update 
Relevancy:
35.21% 
 
Date/Time:
September 24, 2009   2:45pm - 3:15pm
 
Length:
33m 08s - 33 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Dana N. Rutledge, RN, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
U105 - How Successful is Radiation Therapy for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer? Can it be Used for Superficial Bladder Cancer? 
Relevancy:
45.86% 
 
Date/Time:
September 24, 2009   3:30pm - 4:00pm
 
Length:
37m 45s - 56 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Howard Sandler, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM106 - JAK2 Mutations in MPD: A Worthy Therapeutic Target? 
Relevancy:
76.41% 
 
Date/Time:
September 24, 2009   4:05pm - 4:35pm
 
Length:
48m 47s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Olatoyosi Odenike, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
U107 - Surgical Choices for Renal Cell Carcinoma that Optimize Long-Term Renal Function: Open or Laparoscopic? Partial or Complete Nephrectomy? 
Relevancy:
23.32% 
 
Date/Time:
September 24, 2009   4:35pm - 5:05pm
 
Length:
34m 23s - 67 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
William Huang, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 25, 2009 - Friday
 
B201 - Neoadjuvant Therapy for Breast Cancer: Lessons Learned and New Directions with Targeted Therapeutics 
Relevancy:
27.14% 
 
Date/Time:
September 25, 2009   8:50am - 9:20am
 
Length:
25m 58s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Laura J. Esserman, MD, MBA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY201 - The Evolving Role of Systemic Therapy in Endometrial Carcinoma 
Relevancy:
52.12% 
 
Date/Time:
September 25, 2009   8:50am - 9:20am
 
Length:
26m 34s - 24 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Harry J. Long, MD, FACP (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
B203 - Update on Hormone Therapy for Early Stage Breast Cancer: What Treatment, What Duration? 
Relevancy:
32.34% 
 
Date/Time:
September 25, 2009   1:30pm - 2:00pm
 
Length:
28m 33s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Hope S. Rugo, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY204 - Evidence-Based Management of Newly Diagnosed Ovarian Carcinoma 
Relevancy:
65.82% 
 
Date/Time:
September 25, 2009   2:05pm - 2:35pm
 
Length:
34m 08s - 62 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
J. Tate Thigpen, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON205 - Update on Wound Care for Cancer Patients 
Relevancy:
28.92% 
 
Date/Time:
September 25, 2009   2:40pm - 3:10pm
 
Length:
29m 26s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Robin Gemmill, MSN, RN, CNS (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
B206 - Management of Brain Metastases: New Treatment Modalities 
Relevancy:
22.84% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
33m 45s - 57 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Michelle Melisko, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY206 - A Rational Approach to the Use of Systemic Therapy in Recurrent or Persistent Ovarian Carcinoma 
Relevancy:
34.94% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
36m 03s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Herzog, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
B207 - Update on New Treatments for HER2 
Relevancy:
66.27% 
 
Date/Time:
September 25, 2009   4:40pm - 5:10pm
 
Length:
37m 06s - 54 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Hope S. Rugo, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 26, 2009 - Saturday
 
rating
L301 - Multi-modality Treatment Strategies in the Treatment of Curative Lung Cancer 
Relevancy:
100.00% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
25m 45s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Wayne L. Hofstetter, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC304 - Cardiac Complications of Old and New "Targeted" Therapies 
Relevancy:
38.67% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
37m 00s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Anju Nohria, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L305 - What is New in Radiotherapy and the Management of NSCLC? 
Relevancy:
68.83% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
21m 49s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Quynh-Thu Le, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
SC305 - Overview of New Developments in Patient Communication 
Relevancy:
23.93% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
28m 52s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Smith (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC308 - New Developments in Anemia and White Cell Growth Factor Management 
Relevancy:
42.75% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
31m 47s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Smith (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
25 Results Found, Showing 1 - 25